Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Protein Organization01:24

Protein Organization

7.0K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
7.0K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.4K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Protein-protein Interfaces02:04

Protein-protein Interfaces

13.2K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Transcriptomic Signatures of Immune Response Modulation Following Antiretroviral Therapy in HIV-Infected Patients.

International journal of molecular sciences·2025
Same author

Prediction of viral protease inhibitors using proteochemometrics approach.

Computational biology and chemistry·2024
Same author

The method predicting interaction between protein targets and small-molecular ligands with the wide applicability domain.

Computational biology and chemistry·2022
Same author

In Silico Prediction of Drug-Drug Interactions Mediated by Cytochrome P450 Isoforms.

Pharmaceutics·2021
Same author

Spatial features of proteins related to their phosphorylation and associated structural changes.

Proteins·2017
Same author

Prediction of amino acid positions specific for functional groups in a protein family based on local sequence similarity.

Journal of molecular recognition : JMR·2015

Related Experiment Video

Updated: Sep 12, 2025

A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.9K

Comparative efficiency of structure activity relationship and proteochemometric modelling.

Georgy S Malakhov1, Dmitry A Karasev2, Boris N Sobolev2

  • 1Department of Bioinformatics, Institute of Biomedical Chemistry, 119121, Moscow, Russia; Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, 119991, Moscow, Russia.

Journal of Molecular Graphics & Modelling
|August 9, 2025
PubMed
Summary
This summary is machine-generated.

Proteochemometrics (PCM) does not outperform structure-activity relationship (SAR) for predicting known drug ligands. Current validation methods inflate PCM scores, making a transparent validation scheme crucial for accurate method comparison.

Keywords:
ProteochemometricsStructure-activity relationshipValidation schemeVirtual screening

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

357
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

14.4K

Related Experiment Videos

Last Updated: Sep 12, 2025

A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

68.9K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

357
Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry
07:33

Analyzing Protein Architectures and Protein-Ligand Complexes by Integrative Structural Mass Spectrometry

Published on: October 15, 2018

14.4K

Area of Science:

  • Computational chemistry
  • Cheminformatics
  • Drug discovery

Background:

  • Virtual screening is key for identifying drug leads.
  • Structure-activity relationship (SAR) models compare chemical structures.
  • Proteochemometrics (PCM) integrates protein target descriptors, extending SAR capabilities.

Purpose of the Study:

  • To rigorously compare SAR and PCM for predicting ligands of known protein targets.
  • To evaluate the impact of validation schemes on method performance.
  • To address the prevalent, yet unproven, claims of PCM superiority over SAR in specific applications.

Main Methods:

  • Development of a specialized validation scheme for comparing SAR and PCM.
  • Application of both SAR and PCM to predict ligands for proteins with established ligand spectra.
  • Comparative analysis of prediction performance under the new validation scheme.

Main Results:

  • No significant advantage of PCM over SAR was found for predicting ligands of proteins with known ligand spectra.
  • Standard validation procedures for PCM models inflate performance metrics.
  • The commonly used validation scheme leads to overestimated PCM efficacy compared to SAR.

Conclusions:

  • PCM does not demonstrate superiority over SAR for predicting ligands of proteins with established ligand spectra.
  • Current PCM validation practices can be misleading, inflating performance scores.
  • A transparent and appropriate validation strategy is essential for reliable method comparison in drug discovery research.